Pages that link to "Q45960509"

The following pages link to Why did tarenflurbil fail in Alzheimer's disease? (Q45960509):

Displaying 23 items.

• How do immune cells support and shape the brain in health, disease, and aging? (Q26995364) (← links)
• R-flurbiprofen improves tau, but not Aß pathology in a triple transgenic model of Alzheimer's disease (Q30684317) (← links)
• Alzheimer's disease: clinical trials and drug development (Q33349401) (← links)
• Potential therapeutic strategies for Alzheimer's disease targeting or beyond β-amyloid: insights from clinical trials (Q34014237) (← links)
• Current and emerging drug treatment options for Alzheimer's disease: a systematic review. (Q34222721) (← links)
• Targets for AD treatment: conflicting messages from γ-secretase inhibitors (Q34792043) (← links)
• An NSAID-like compound, FT-9, preferentially inhibits gamma-secretase cleavage of the amyloid precursor protein compared to its effect on amyloid precursor-like protein 1. (Q35809939) (← links)
• Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia (Q35813037) (← links)
• Efficacy of SPI-1865, a novel gamma-secretase modulator, in multiple rodent models (Q36998748) (← links)
• Amyloid-modifying therapies for Alzheimer's disease: therapeutic progress and its implications (Q37773826) (← links)
• γ-Secretase Modulators as Potential Disease Modifying Anti-Alzheimer’s Drugs (Q37818108) (← links)
• Current perspectives on pharmacotherapy of Alzheimer's disease (Q37827489) (← links)
• Novel γ-secretase modulators: a review of patents from 2008 to 2010 (Q37828163) (← links)
• The value and limitations of transgenic mouse models used in drug discovery for Alzheimer's disease: an update (Q37998086) (← links)
• Apolipoprotein E-mediated Modulation of ADAM10 in Alzheimer's Disease (Q38977248) (← links)
• Targeting neuroinflammation in Alzheimer's disease: evidence for NSAIDs and novel therapeutics (Q39689655) (← links)
• NSAID-based γ-secretase modulators do not bind to the amyloid-β polypeptide (Q40867620) (← links)
• γ-Secretase Modulators: Can We Combine Potency with Safety? (Q42071699) (← links)
• Modulation of gamma-secretase for the treatment of Alzheimer's disease (Q42286536) (← links)
• Role of serum albumin as a nanoparticulate carrier for nose-to-brain delivery of R-flurbiprofen: implications for the treatment of Alzheimer's disease. (Q42516901) (← links)
• Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment? (Q42659546) (← links)
• Synthesis of Ibuprofen Conjugated Molecular Transporter Capable of Enhanced Brain Penetration (Q59145861) (← links)
• BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer's Disease (Q64077439) (← links)